Why Should We Start Using Narrow Spectrum Antibiotics?
SEP 12, 2016 | CONTAGION EDITORIAL STAFF
Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, discusses the advantages of narrow spectrum antibiotics.
Interview Transcript (slightly modified for readability)
“By narrowing in on specific organisms and specifically targeting and going after, say, [Streptococcus] mutans in my case, or [Clostridium] difficile, which there [are] a lot of people that are looking at very narrow spectrum C. diff targets, you’re sparing other bacteria in the microbiome, the bulk of all the bacteria you have in your body.
By sparing those other bacteria, you’re not putting selective pressure on those other bacteria to evolve to be resistant to the antibacterials that you are using. So yes, absolutely: narrow spectrum antibacterial use will limit the development of bacterial resistance.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512